Literature DB >> 10199238

Host protein incorporation is conserved among diverse HIV-1 subtypes.

B D Roberts, S T Butera.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199238     DOI: 10.1097/00002030-199902250-00020

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection.

Authors:  S D Lawn; S T Butera
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.

Authors:  S D Lawn; B D Roberts; G E Griffin; T M Folks; S T Butera
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation.

Authors:  M T Esser; D R Graham; L V Coren; C M Trubey; J W Bess; L O Arthur; D E Ott; J D Lifson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Adaptation of wild-type measles virus to tissue culture.

Authors:  Diane Waku Kouomou; T Fabian Wild
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 5.  The Incorporation of Host Proteins into the External HIV-1 Envelope.

Authors:  Jonathan Burnie; Christina Guzzo
Journal:  Viruses       Date:  2019-01-20       Impact factor: 5.048

Review 6.  Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents.

Authors:  Mayte Coiras; Emilio Camafeita; María Rosa López-Huertas; Enrique Calvo; Juan Antonio López; José Alcamí
Journal:  Proteomics       Date:  2008-02       Impact factor: 3.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.